Our website is live!
Similar Posts
Carlos Huesa receives the American Cancer Society Postdoctoral Fellowship
ByadminWe are thrilled to announce that Dr. Carlos Huesa-Berral has been awarded a postdoctoral fellowship from the American Cancer Society. for his project entitled “Computational Modeling and Simulation of Hepatic Tumors for Enhanced Transarterial Radioembolization”. Carlos will start this 3-year-long project on January 1st, 2025. This fellowship is highly competitive, with only a small percentage…
New collaborative publications out
ByadminWe are pleased to announce two new collaborative publications from our team: Dr. Bertolet collaborated with Dr. Ibrahim Chamseddine and Dr. Charles Maitz from the University of Missouri on a recent publication in Veterinary and Comparative Oncology. This paper investigates preclinical studies in dogs, emphasizing how the distribution of iodine-131 influences therapeutic outcomes.Access the paper…
The B-Lab 2024
ByadminAs we close out 2024, we reflect on the remarkable growth of the Bertolet Lab during its second year. Formally established in the summer of 2023, our lab has thrived through a year of achievements and hard-fought progress. Beyond the accomplishments listed below, we have had the privilege of working with remarkable individuals whose energy,…
Congratulations to Carlos Huesa: Celebrating a Remarkable Achievement in Malaga
ByadminWe are thrilled to share the exciting news that our postdoctoral fellow, Dr. Carlos Huesa-Berral, has been honored by his birth city, Malaga (Spain), as part of the prestigious awards granted by COPE Radio. Carlos was recognized as the Malaga citizen with the most significant international trajectory for his outstanding contributions to Radiation Oncology research…
Initiating a collaboration with the University of Pennsylvania on an exciting new R01 project
ByadminWe are thrilled to announce that we held our first meeting yesterday with the University of Pennsylvania, marking the commencement of an inspiring collaboration. Our teams are eager to dedicate their expertise towards a crucial R01 project: “Optimizing theranostic radiopharmaceutical therapy to combat resistance to PARP inhibition in advanced ovarian cancer.” This collaboration is a…
New publication in the Red Journal – TOPAS-RPT
ByadminWe’re excited to share our new paper in the prestigious IJROBP (aka the Red Journal), first-authored by Dr. Victor V. Onecha, where we’ve taken a big step toward making targeted α-particle therapies safer and more precise. We did this work in collaboration with Drs. Daniel Pryma and Sarah Gitto at the University of Pennsylvania. Here’s…
